TITLE

Craniofacial Growth in Short Children Born Small for Gestational Age: Effect of Growth Hormone Treatment

AUTHOR(S)
Van Erum, R.; Mulier, M.; Carels, C.; Verbeke, G.; De Zegher, F.
PUB. DATE
September 1997
SOURCE
Journal of Dental Research;Sep1997, Vol. 76 Issue 9, p1579
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The effects of growth hormone (GH) therapy in children have yet to be completely catalogued. In the present study, the effect of high-dose GH treatment on craniofacial growth was evaluated once yearly in 21 pre-pubertal, non-GH-deficient children born small for gestational age. These children were randomly allocated to be either untreated or treated with GH at a daily subcutaneous dose of 0.2 or 0.3 IU/kg for 2 yrs. The group consisted of 12 girls and 9 boys with a mean age of 5.1 yr (range, 2 to 8 yr), bone age of 3.4 yr, and height SDS of -3.6. At the start of the study, all children showed an overall delay of craniofacial growth. This cohort of short children born small for gestational age showed a small SNB angle and a large ANB angle; all other angular measurements were within normal range. GH treatment accelerated growth in several craniofacial components, especially the posterior total facial height, the cranial base length, and the overall mandibular length. The increase of the mandibular length increased the SNB angle; no other angular measurements were affected. Age at start of treatment differently influenced the increase in posterior and total cranial base length, the increase in mandibular corpus length, and the position of the mandible in relation to the cranial base. Although GH treatment for 2 yrs led to a craniofacial growth acceleration, the position of the mandible in relation to the cranial base and the craniofacial size in lateral aspect were not normalized in the majority of the GH-treated children. No signs of disproportional growth were evidenced after 2 yrs of high-dose GH treatment. In conclusion, short pre-pubertal SGA children display an overall delay of linear craniofacial growth and a retrognathic mandible. High-dose GH treatment over 2 yrs leads to craniofacial catch-up growth, which is pronounced in regions where interstitial cartilage is involved and results in a less convex face in profile.
ACCESSION #
36489913

 

Related Articles

  • The effect of growth hormone therapy on mandibular and cranial base development in children treated with total body irradiation. Forsberg, Carl-Magnus; Krekmanova, Larisa; Dahllöf, Göran // European Journal of Orthodontics;Jun2002, Vol. 24 Issue 3, p285 

    The aim of the present investigation was to study craniomandibular development during growth hormone (GH) therapy in nine girls and one boy, aged between 7.3 and 16 years, who exhibited pronounced growth reduction after total body irradiation (TBI) and bone marrow transplantation (gMT). Age- and...

  • Efficacy and safety of growth hormone treatment for children born small for gestational age. Il Tae Hwang // Korean Journal of Pediatrics;2014, Vol. 57 Issue 9, p379 

    Recombinant growth hormone (GH) is an effective treatment for short children who are born small for gestational age (SGA). Short children born SGA who fail to demonstrate catch-up growth by 2-4 years of age are candidates for GH treatment initiated to achieve catch-up growth to a normal height...

  • Veličina donje vilice kao rani pokazatelj razvoja skeletne klase III. Stojanović, Zdenka; Nikodijević, Angelina; Udovičić, Božidar; Milić, Jasmina; Nikolić, Predrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Aug2008, Vol. 65 Issue 8, p589 

    Malocclusion of skeletal class III is a complex abnormality, with a characteristic sagital position of the lower jaw in front of the upper one. A higher level of prognatism of the lower jaw in relation to the upper one can be the consequence of its excessive length. The aim of this study was to...

  • SPEED EQUALS SIZE.  // Joe Weider's Muscle & Fitness;Dec2009, Vol. 70 Issue 12, p45 

    The article reports that according to a new study, to boost growth hormone (GH) levels during workouts, one should have rest intervals of one minute between sets. The study, conducted by researchers from the University of Brasilia, Brazil, was published in the "Journal of Science & Medicine in...

  • Somatropin.  // Reactions Weekly;2/2/2013, Issue 1437, p27 

    The article describes the case of a 12-year-old girl with Turner's syndrome who developed bilateral slipped capital femoral epiphysis after receiving somatropin.

  • Somatrogon: Pseudo tumour cerebri: case report.  // Reactions Weekly;6/29/2019, Vol. 1759 Issue 1, p244 

    The article describes the case of a 6-year-old girl who presented with pseudo tumour cerebri while receiving somatrogon for pycnodysostosis.

  • CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA): A NEW FRONTIER FOR GH THERAPY. Popa, M. // Acta Endocrinologica (1841-0987);Jul-Sep2007, Vol. 3 Issue 3, p371 

    A 9 member independent panel of endocrinologists and pediatricians was convened to discuss basic issues with respect to definition, diagnosis, and clinical management of children born small for gestational age (SGA). SGA is defined as the situation when birth weight and/or length are at least 2...

  • Rendgen-kefalometrijska procena linearnih i angularnih parametara na bazi lobanje kod dece sa III skeletnom klasom. Stojanović, Zdenka M.; Milić, Jasmina; Nikolić, Predrag // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Sep2007, Vol. 64 Issue 9, p604 

    Background/Aim. In malocclusion of skeletal class III, mandible is located in front of maxilla in sagital plain, which is manifested by a lower value of the sagital inter-jaw angle than in skeletal class I, where the jaw sagital relation is normal. Apart from the deformities on mandible and/or...

  • The Role of Growth Hormone and Insulin-Like Growth Factor-1 in the Treatment of Idiopathic Short Stature. Kemp, Stephen F.; Frindik, J. Paul // Current Medical Literature: Growth, Growth Hormone, & Metabolism;2006, Vol. 1 Issue 4, p98 

    The article discusses literature concerning the role of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in the treatment of children with idiopathic short stature (ISS). The efficacy and safety of GH tretament in ISS is explored. The psychosocial effect of treating ISS is also...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics